Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan Pharmaceuticals in Canada is voluntarily recalling all 100-count bottles of a single product lot, number 1037180, which were distributed to wholesalers and pharmacies and subsequently notified Health Canada of this action.
Subscribe to our email newsletter
Mylan received a report from a pharmacist who had received several bottles of Mylan-Minocycline Capsules, 50 mg, including one bottle that was mislabeled as another product (Mylan-Amlodipine Tablets, 5 mg).
The mislabeled bottle did contain Mylan-Minocycline Capsules, 50 mg.
Mylan said the 250-count bottles that were distributed to wholesalers and pharmacies with the same lot number are not part of this recall.
Mylan-Minocycline, a generic version of Minocin, is an antibiotic indicated for the treatment of various types of infections.
Mylan-Amlodipine, a generic version of Norvasc, is used to treat hypertension (high blood pressure) and angina (chest pain).